CRISPR in cells service now available

Share this:

The Monash Genome Modification Platform (MGMP), in alliance with Phenomics Australia, provides a comprehensive service in genetic modification and has recently added CRISPR/Cas9 gene-editing in cells to the list of services offered.

CRISPR technology enables the production of a number of mutations not previously possible using conventional gene targeting.  We can generate knock-out, knock-in, point-mutated and tagged versions of your favourite gene in a wide variety of both human and mouse cell lines. 

We offer a full service, from project design to delivery of modified clones, and supported by NCRIS funding, this service is available to researchers at a heavily subsidised price.

Use one of our proven cell lines:

hESC, HEK293, MDA-MB-231, A549, MCF7, KPC, C26, mESC

or suggest your own to use, we are happy to discuss the possibilities.

Cell line modification using CRISPR or traditional gene targeting in ES cells.
Click Here
Cloning and DNA preparation
Click Here
Rodent genome modification using CRISPR, ES cell & transgenic technologies.
Click Here
Previous slide
Next slide

‘ Whether you are interested in generating a modified rodent or cell line or would like to take advantage of our excellent cloning service, we’d love to hear from you. Contact us’

Phenomics Australia In Vitro Genome Engineering and Disease Modelling. In addition to the current services on offer, Phenomics Australia is making a significant step towards establishing a broad panel of new in vitro genome engineering and disease modelling services in Australia for the purposes of discovering gene function, modelling disease and therapeutic development. This includes, for example, models using cell lines, iPS cells, cell & tissue cultures, organoids, and “on-a-chip” systems. These will offer an accessible complement to the in vivo capabilities currently provided by Phenomics Australia. 

More:

Phenomics Australia Feedback Form

Phenomics Australia (formerly the Australian Phenomics Network, APN) offers consolidated infrastructure and expertise supporting genomic medicine and biomedical research from discovery through into early clinical development and evaluation.

Phenomics Australia is a founding capability enabled by the National Collaborative Research Infrastructure Strategy (NCRIS). We would love to hear from you!

Please feel free to provide any ideas or general comments you might have so that we can further improve how Phenomics Australia can support you.

Phenomics Australia PHENOMENA News Contribution

Have you recently had a publication accepted? Do you want to tell us about a grant you have received? Or maybe you have just been recently in the news? You can complete this form to tell us about your latest research developments.

Information provided will be used to inform press releases, website stories, social media content and more. This form is being used to capture everything that is happening at Phenomics Australia, which can then be used as part of our outreach and communications.

Once you have completed the form, the Communications and Outreach Coordinator will then be in contact with you.

Thanks.

Make an Enquiry

_Get in touch to discuss how we can help with your research.